Comité Científico

D. Shalom Isaac Benrimoj

Vocal

Emeritus Prof, Universidad de Sidney, Australia

Biografía


Emeritus Professor S.I. (Charlie) Benrimoj B. Pharm (Hons), Ph.D. F.P.S., FRPSGB, FFIP was the Foundation Professor of Pharmacy Practice (1991), Dean of the Faculty of Pharmacy (2000 to 2005), Pro-Vice Chancellor (Strategic Planning) (2006 to 2011) University of Sydney and Director and Head of Graduate School of Health at the University of Technology Sydney (2011- 2018).

He was a visiting professor at the University of Granada. Research interests encompass the future and the delivery of professional cognitive pharmaceutical services from community pharmacy in current and emergent health services. These include the role of community pharmacy in self-care, adherence, patient medication reviews, disease state management, minor ailments, remuneration systems, integration in primary health care and international pharmacy practice. Specific research programs include impact study and evaluation of clinical, economic and humanistic impacts of services and their implementation into usual practice. He has published over 250 papers in refereed journals, produced 47 major research reports and co-authored over 300 scientific conference presentations.

He has been a keynote speaker in over 150 national and international conferences. He was the Australian Pharmacist of the year in 2000. He has been active at international level as the Chair, SIG Pharmacy Practice Research, Board of Pharmaceutical Science, International Pharmaceutical Federation (FIP 2016-2019), Chair, Innovators Forum International Pharmaceutical Federation (FIP 2006-2015)). He was awarded the Andre Bedat Award International Federation of Pharmacy (FIP), the highest award attainable by a pharmacist for significant international contribution to pharmacy practice, a FIP Fellowship in 2007, a Fellowship of the Royal Pharmaceutical Society of Great Britain in 2008 and a Fellowship of the Pharmaceutical Society of Australia, 2008. In 2022 he was listed in the top 2% of influential researchers in the University of Stanford rankings.